LIV WOMAN Trademark

Trademark Overview


On Wednesday, March 5, 2025, a trademark application was filed for LIV WOMAN with the United States Patent and Trademark Office. The USPTO has given the LIV WOMAN trademark a serial number of 99069304. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, July 29, 2025. This trademark is owned by Epimorphy LLC. The LIV WOMAN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information; Biological research laboratory services
liv woman

General Information


Serial Number99069304
Word MarkLIV WOMAN
Filing DateWednesday, March 5, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, July 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding medical and scientific research information; Biological research laboratory services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 5, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEpimorphy LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTustin, CA 92780

Trademark Events


Event DateEvent Description
Wednesday, March 5, 2025NEW APPLICATION ENTERED
Wednesday, March 5, 2025APPLICATION FILING RECEIPT MAILED
Thursday, July 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 21, 2025ASSIGNED TO EXAMINER
Tuesday, July 29, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 29, 2025NON-FINAL ACTION E-MAILED
Tuesday, July 29, 2025NON-FINAL ACTION WRITTEN